Effects of Intranasal Insulin Pretreatment on Preoperative Sleep Quality and Postoperative Delirium in Patients Undergoing Valve Replacement for Rheumatic Heart Disease
DOI: https://doi.org/10.2147/nss.s439703
2024-05-29
Nature and Science of Sleep
Abstract:Qingqing Huang, 1, 2 Xiao Wu, 1, 3 Ni Lei, 1 Xin Chen, 4 Sixun Yu, 4 Xuemei Dai, 1 Qin Shi, 1, 3 Gu Gong, 1, &ast Hai-Feng Shu 2, 4, &ast 1 Department of Anesthesiology, The General Hospital of Western Theater Command, Chengdu, People's Republic of China; 2 College of Medicine, Southwest Jiaotong University, Chengdu, People's Republic of China; 3 Department of Anesthesiology, North Sichuan Medical College, Nanchong, People's Republic of China; 4 Department of Neurosurgery, The General Hospital of Western Theater Command, Chengdu, People's Republic of China &astThese authors contributed equally to this work Correspondence: Gu Gong, Department of Anesthesiology, The General Hospital of Western Theater Command, 270 Tianhui Road, Rongdu Avenue, Jinniu District, Chengdu, Sichuan, 610083, People's Republic of China, Tel +8617360137572, Fax +86 028571770, Email Background: Postoperative delirium (POD) is a common neurological complication associated with valve replacement. Preoperative sleep disturbance is a risk factor for POD development, and nasal insulin modulates the sleep-wake cycle. This study investigated the beneficial effects of intranasal insulin pretreatment on preoperative sleep quality and reducing POD in patients undergoing valve replacement for rheumatic heart disease. Patients and Methods: This prospective, single-center, randomized controlled trial (RCT) included 76 adult patients aged 18– 65 years undergoing valve surgery with cardiopulmonary bypass who were randomly allocated to receive intranasal insulin or normal saline interventions two days before surgery. POD incidence was on postoperative days 1 (T3), 2 (T4), and 3 (T5). Before the first intervention (T0), 1 d before surgery (T1), and before anesthesia on the day of surgery (T2), sleep quality was assessed and serum cortisol concentrations were measured. At T1 and T2, sleep quality related indicators monitored by sleep monitoring watches from the previous night were recorded. Results: Compared with the normal saline group, 3 days after surgery, the insulin group showed a significantly reduced incidence of POD; significantly increased deep sleep, REM sleep, deep sleep continuity, and total sleep quality scores at T1 and T2; and significantly reduced serum cortisol concentration, PSQI scale, light sleep ratio, and wakefulness at T1 and T2. Conclusion: The administration of 20 U of intranasal insulin twice daily, from 2 days preoperatively until 10 minutes preanesthesia on the day of surgery, can improved preoperative sleep quality significantly and reduced POD incidence in patients with rheumatic heart disease undergoing valve replacement. Clinical Trial Registration: This study was registered with the Chinese Clinical Trial Registry ( www.chictr.org.cn , with the unique identifier ChiCTR2100048515; July 9, 2021). Keywords: postoperative delirium, rheumatic heart disease, valve replacement, preoperative sleep quality, intranasal insulin Rheumatic heart disease occurs when the mitral, tricuspid, aortic, or pulmonary valves develop lesions due to rheumatic fever that interfere with normal blood flow, resulting in abnormal heart function. 1 Currently, valve replacement is the most effective surgical treatment. Preoperative negative emotions such as fear and anxiety, in patients undergoing valve replacement surgery due to uncertainties regarding the operation procedure can seriously affect patient sleep quality. 2 Sleep is crucial for maintaining optimal brain function. 3 Research 4 has shown that insufficient sleep can lead to an increase in the release of inflammatory cytokines, thereby activating microglia. When microglia are activated, they release inflammatory cytokines, exacerbating damage to the nervous system. In addition, insufficient sleep can cause excessive excitement of the hypothalamic pituitary adrenal axis, leading to the transfer of a large amount of cortisol produced to the central nervous system, activating the BDNF/TrkB signaling pathway, causing neuronal apoptosis in the hippocampus, and thus causing cognitive impairment. 5 In patients with obstructive sleep apnea syndrome, sleep efficiency is often affected, leading to excessive sleepiness, fatigue during the day, and an increased risk of cardiovascular or neurodegenerative diseases. 6,7 In recent years, sleep has gradually become a hot topic in clinical research owing to its potential impact on cognitive function. Among these research findings is that preoperative sleep disruption predicts post -Abstract Truncated-
neurosciences,clinical neurology